COMMUNIQUÉS West-GlobeNewswire

Photocure ASA: Results for the third quarter of 2017

08/11/2017 - 07:17

Oslo, Norway, 7 November 2017: Photocure ASA (OSE: PHO ), today reported a revenue growth of 45% for the important US market in the third quarter of 2017, contributing to Hexvix/Cysview revenues of NOK 35.5 million (Q3 [...]

Voyager Therapeutics Announces Pricing of Public Offering of Common Stock

08/11/2017 - 04:55

CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]

VALNEVA Signs $39.6 Million IXIARO® Supply Contract with US Government

08/11/2017 - 02:06

Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial stage biotech company focused on developing innovative, life-saving vaccines, announces today the signing of a $39.6 million one year contract with [...]

Sun BioPharma Announces Execution of Reverse Stock Split

08/11/2017 - 01:21

MINNEAPOLIS, Minn., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, announced [...]

Corizon Health Partners with Missouri Department of Corrections to Serve Incarcerated Veterans

07/11/2017 - 23:49

BRENTWOOD, Tenn., Nov. 07, 2017 (GLOBE NEWSWIRE) -- US military veterans account for an estimated 181,500 inmates in US prisons and jails, according to the most recent numbers available from the federal Bureau of [...]

Almost Family Reports Third Quarter and Year to Date 2017 Results

07/11/2017 - 23:21

LOUISVILLE, Ky., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Almost Family, Inc. (NASDAQ: AFAM ), a leading national provider of home health and related services, announced today its financial results for the quarter ended [...]

National Research Corporation Announces Third Quarter 2017 Results

07/11/2017 - 23:00

LINCOLN, Neb., Nov. 07, 2017 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA ) (NASDAQ: NRCIB ) today announced results for the third quarter of 2017. Net New Sales $5.4 million Total Contract Value $ [...]

Amedisys Reports Third Quarter 2017 Financial Results

07/11/2017 - 23:00

BATON ROUGE, La., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ) today reported its financial results for the three and nine-month periods ended September 30, 2017. Three Month Periods Ended September [...]

Xenon Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update

07/11/2017 - 22:57

BURNABY, British Columbia, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today reported its financial results for the quarter ended September [...]

Profound Medical Corp. Announces Third Quarter 2017 Financial Results

07/11/2017 - 22:45

TORONTO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

ChemoCentryx Reports Third Quarter 2017 Financial Results and Recent Highlights

07/11/2017 - 22:40

-- Phase III ADVOCATE trial of avacopan remains on track to complete enrollment in mid-2018 -- -- Patient enrollment ongoing in registration-supporting trial for avacopan in the treatment C3 Glomerulopathy (C3G) -- -- [...]

Alder BioPharmaceuticals® Announces Third Quarter 2017 Financial and Operating Results

07/11/2017 - 22:24

– PROMISE 2 pivotal trial completed enrollment and top-line data on track for 1H18 – – Eptinezumab Biologics License Application (BLA) submission on track for 2H18 – – Conference call scheduled for 5 p.m. ET today – [...]

REVA Medical Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:15

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported financial results for [...]

Akcea to Present at Stifel 2017 Healthcare Conference

07/11/2017 - 22:15

CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

07/11/2017 - 22:08

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings

07/11/2017 - 22:05

Revenue increased 307% and 87%, respectively, compared to the three and nine month periods in the prior year driven by development efforts supporting Pharma clinical programs TUCSON, Ariz., Nov. 07, 2017 (GLOBE NEWSWIRE [...]

Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:05

AUSTIN, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (NASDAQ: AGLE ) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat [...]

Global Blood Therapeutics Announces Participation at the Stifel 2017 Healthcare Conference

07/11/2017 - 22:05

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that it will present at the Stifel 2017 Healthcare Conference in New York City on [...]

Novavax Reports Third Quarter 2017 Financial Results

07/11/2017 - 22:05

GAITHERSBURG, Md., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX ) today announced its financial results for the third quarter and nine months ended September 30, 2017. Third Quarter Achievements: [...]